MyAverix Finance
AU · Healthcare
Cynata Therapeutics Ltd (CYP)
Biotechnology
Cynata Therapeutics Ltd (CYP) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CYP
Cynata Therapeutics Ltd (CYP) — FAQ
What is CYP's P/E ratio?
The price-to-earnings (P/E) ratio for Cynata Therapeutics Ltd (CYP) is 18.00 (data as of 2026-03-23).
Does Cynata Therapeutics Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Cynata Therapeutics Ltd (CYP). Check the MyAverix Finance app for the latest dividend data.
What sector is Cynata Therapeutics Ltd in?
Cynata Therapeutics Ltd (CYP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CYP listed on?
CYP is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.